EMPLOYMENT AGREEMENTEmployment Agreement • June 27th, 2018 • Neos Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
This Employment Agreement (“Agreement”) is made by and between Neos Therapeutics, Inc., a Delaware corporation (the “Company”), and Jerry McLaughlin (the “Executive”).
Re: Separation Agreement and ReleaseSeparation Agreement and Release • June 27th, 2018 • Neos Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Thank you for your services to Neos Therapeutics, Inc. (the “Company”). As we have discussed, the Company has decided to end your employment. For purposes of this letter agreement, the termination of your employment shall be without Cause pursuant to Section 3(d) of your Amended and Restated Employment Agreement with the Company dated July 10, 2015 (the “Employment Agreement”). This letter agreement constitutes a “Notice of Termination” as provided for in Section 3(f) of the Employment Agreement as well as the “Separation Agreement and Release” as provided for in Section 4(b) of the Employment Agreement (the “Agreement”). As you know, in order to receive the Severance Amount (as defined in your Employment Agreement) and post-employment benefits provided for in Section 4(b) of the Employment Agreement, this Agreement must become effective as set forth below.
